Á lódáil...

Naltrexone extended-release injection: an option for the management of opioid abuse

The United States Food and Drug Administration (FDA) approved naltrexone, a synthetic competitive antagonist at opioid receptors, in oral form in 1984 for use in the management of opioid abuse and addiction. Because naltrexone and its major metabolite, 6-β-naltrexone, are both competitive antagonist...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Taylor, Robert, Raffa, Robert B, Pergolizzi, Joseph V
Formáid: Artigo
Teanga:Inglês
Foilsithe: Dove Medical Press 2011
Ábhair:
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3846318/
https://ncbi.nlm.nih.gov/pubmed/24474859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/SAR.S17920
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!